Abstract
The pharmacokinetics and pharmacodynamics of racemic acenocoumarol (AC), the amino (AM) and acetamido (AA) derivative were investigated in healthy volunteers after administration of a single oral (10 mg) dose. All three coumarins were rapidly absorbed from the gastrointestinal tract. The elimination half-lives were 10.9, 10.4, and 4.1 h, for AC, AM and AA, respectively. After the oral administration of AC, no AM and AA was detected in the plasma, and less than 1% of the dose was recovered in the urine (0-24 h) as AM. Renal clearance was the main route of elimination of AM and AA; the former by glomerular filtration, the latter by active excretion. Binding to serum proteins was the highest for AC (1.52% free). AM and AA were less tightly bound (about 3% free). AM or AA did not interfere with the AC plasma protein binding. The oral administration of AC resulted in a rise in prothrombin time with a maximum effect at 24 to 30 h. No anticoagulant activity was observed upon the administration of AM and AA. The results indicate that the compounds AM and AA, if they are formed out of AC at all, do not contribute to the anticoagulant activity of AC.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dieterle W., Faigle J. W., Montigel C., Sulc M., Theobald W. Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man. Eur J Clin Pharmacol. 1977;11(5):367–375. doi: 10.1007/BF00566534. [DOI] [PubMed] [Google Scholar]
- Gillette J. R., Kamm J. J., Sasame H. A. Mechanism of p-nitrobenzoate reduction in liver: the possible role oc cytochrome P-450 in liver microsomes. Mol Pharmacol. 1968 Nov;4(6):541–548. [PubMed] [Google Scholar]
- Godbillon J., Richard J., Gerardin A., Meinertz T., Kasper W., Jähnchen E. Pharmacokinetics of the enantiomers of acenocoumarol in man. Br J Clin Pharmacol. 1981 Nov;12(5):621–629. doi: 10.1111/j.1365-2125.1981.tb01280.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hewick D. S., Shaw V. The importance of the intestinal microflora in nitrazepam metabolism in the rat [proceedings]. Br J Pharmacol. 1978 Mar;62(3):427P–427P. [PMC free article] [PubMed] [Google Scholar]
- Houwert-de Jong M., Gerards L. J., Tetteroo-Tempelman C. A., de Wolff F. A. May mothers taking acenocoumarol breast feed their infants? Eur J Clin Pharmacol. 1981;21(1):61–64. doi: 10.1007/BF00609589. [DOI] [PubMed] [Google Scholar]
- Jochemsen R., Van Beusekom B. R., Spoelstra P., Janssens A. R., Breimer D. D. Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam. Br J Clin Pharmacol. 1983 Mar;15(3):295–302. doi: 10.1111/j.1365-2125.1983.tb01502.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levin A. A., Dent J. G. Comparison of the metabolism of nitrobenzene by hepatic microsomes and cecal microflora from Fischer-344 rats in vitro and the relative importance of each in vivo. Drug Metab Dispos. 1982 Sep-Oct;10(5):450–454. [PubMed] [Google Scholar]
- Meinertz T., Kasper W., Kahl C., Jähnchen E. Anticoagulant activity of the enantiomers of acenocoumarol. Br J Clin Pharmacol. 1978 Feb;5(2):187–188. doi: 10.1111/j.1365-2125.1978.tb01622.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thijssen H. H., Baars L. G., Reijnders M. J. Analysis of acenocoumarin and its amino and acetamido metabolites in body fluids by high-performance liquid chromatography. J Chromatogr. 1983 May 13;274:231–238. doi: 10.1016/s0378-4347(00)84426-6. [DOI] [PubMed] [Google Scholar]
- Wheeler L. A., Soderberg F. B., Goldman P. The relationship between nitro group reduction and the intestinal microflora. J Pharmacol Exp Ther. 1975 Jul;194(1):135–144. [PubMed] [Google Scholar]